文献速递血管炎

新诊断巨细胞动脉炎患者的超声随访检查

Follow-up ultrasound examination in patients with newly diagnosed giant cell arteritis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

本研究前瞻性纳入50例新诊断巨细胞动脉炎(GCA)患者,在基线及3、6、9、12个月时行面部、颞、颈、椎及腋动脉超声,评估内膜中层厚度(IMT)、受累动脉总数及暂定OMERACT GCA超声评分(OGUS)的变化。结果观察到IMT、受累动脉总数及OGUS均显著下降;腋动脉平均IMT在7天后正常化,颞总动脉IMT在50天后正常化;有无PMR或是否加用托珠单抗对IMT下降无差异。

要点

  • 血管超声对GCA的病情变化敏感,随访中IMT、受累动脉数及OGUS均显著下降。
  • 腋动脉平均IMT在7天后正常化,颞总动脉IMT在50天后正常化。
  • 有无PMR或是否加用托珠单抗对IMT下降无差异。

核心结论

  • 血管超声对GCA的病情变化敏感;合并PMR或接受托珠单抗治疗不影响IMT下降。

研究设计与样本

  • 前瞻性纳入新诊断GCA患者,在基线及3、6、9、12个月行面部、颞、颈、椎及腋动脉超声,评估IMT、受累动脉总数及OGUS变化;部分患者在前100天每周检查。
  • 共纳入50例患者,36例完成随访;18例患者接受每周检查。

主要发现

  • 观察到IMT、受累动脉总数及OGUS显著下降。
  • 腋动脉平均IMT在7天后正常化,颞总动脉IMT在50天后正常化。
  • 平均OGUS值在6个月后低于1。
  • 有无PMR或是否加用托珠单抗的GCA患者之间IMT变化无差异。
  • 4例患者复发;复发时平均IMT和OGUS较前次评估升高;未发现可预测复发的指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Ultrasound is a standard tool to diagnose giant cell arteritis (GCA). Until now, only a few studies have investigated the role of ultrasound in the follow-up of GCA. The aim of this study was to assess the changes in the intima-media thickness (IMT), total number of affected arteries and provisional OMERACT GCA ultrasonography score (OGUS) in a 12-months follow-up period. METHODS: Patients with newly diagnosed GCA were prospectively enrolled. Ultrasound examinations of facial, temporal, carotid, vertebral and axillary arteries were performed at baseline, after 3, 6, 9 and 12 months. Changes of IMT, total number of affected arteries and OGUS values were evaluated. In a subgroup of patients, exams were conducted weekly in the first 100 days. RESULTS: Fifty patients were enrolled and 36 completed the follow-up. Significant reductions in IMT, total number of affected arteries and OGUS were observed. Eighteen patients presented to weekly exams. The mean IMT of the axillary artery normalized after 7 days, while IMT of the common temporal artery normalized after 50 days. The mean OGUS values were below 1 after 6 months. There were no differences in IMT changes between GCA patients with or without PMR or between those with and without additional tocilizumab treatment. A relapse occurred in four patients. At relapse, mean IMT and OGUS were higher as compared to the preceding assessment. No predictive values indicating a relapse were identified. CONCLUSION: Vascular ultrasound is sensitive to change in GCA. The presence of PMR or treatment with tocilizumab did not affect IMT decrease.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Schäfer VS, Dejaco C, Karakostas P, et al. Follow-up ultrasound examination in patients with newly diagnosed giant cell arteritis. Rheumatology (Oxford). 2025. PMID: 38366635. doi:10.1093/rheumatology/keae098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。